X4 Pharmaceuticals, Inc. (XFOR)
3.72
-0.13
(-3.38%)
USD |
NASDAQ |
Jun 10, 16:00
3.72
0.00 (0.00%)
After-Hours: 20:00
X4 Pharmaceuticals Debt to Equity Ratio : 0.4586 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.4586 |
| December 31, 2025 | 0.4149 |
| September 30, 2025 | 1.255 |
| June 30, 2025 | 19.65 |
| March 31, 2025 | 3.401 |
| December 31, 2024 | 3.526 |
| September 30, 2024 | 1.312 |
| June 30, 2024 | 0.8282 |
| March 31, 2024 | 56.25 |
| December 31, 2023 | 1.141 |
| September 30, 2023 | 0.8623 |
| June 30, 2023 | 0.546 |
| March 31, 2023 | 0.7147 |
| December 31, 2022 | 0.5188 |
| September 30, 2022 | 0.6195 |
| June 30, 2022 | 1.276 |
| March 31, 2022 | 0.7808 |
| December 31, 2021 | 0.6177 |
| September 30, 2021 | 0.5801 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.447 |
| March 31, 2021 | 0.3723 |
| December 31, 2020 | 0.5281 |
| September 30, 2020 | 0.3452 |
| June 30, 2020 | 0.2649 |
| March 31, 2020 | 0.2346 |
| December 31, 2019 | 0.1773 |
| September 30, 2019 | 0.2909 |
| June 30, 2019 | 0.3029 |
| March 31, 2019 | 0.7737 |
| December 31, 2018 | -0.842 |
| September 30, 2018 | 0.3848 |
| June 30, 2018 | 0.2964 |
| March 31, 2018 | 0.2481 |
| December 31, 2017 | 0.2084 |
| September 30, 2017 | 1.082 |
| June 30, 2017 | 0.701 |
| March 31, 2017 | -0.9157 |
| December 31, 2016 | -0.9126 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Kyverna Therapeutics, Inc. | 0.1726 |
| Arrowhead Pharmaceuticals, Inc. | 2.237 |
| Oncolytics Biotech, Inc. | -0.099 |
| Sangamo Therapeutics, Inc. | -1.020 |
| Sarepta Therapeutics, Inc. | 0.6888 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 270.28M |
| Total Liabilities (Quarterly) | 101.83M |
| Shareholders Equity (Quarterly) | 168.45M |
| Current Ratio | 10.18 |
| Net Debt Paydown Yield | 0.04% |